Literature DB >> 7295522

A comparison of antibody responses to Admune inactivated influenza vaccine in serum and respiratory secretions of healthy non-smokers, healthy cigarette-smokers and patients with chronic bronchitis.

G K Knowles, P Taylor, M Turner-Warwick.   

Abstract

Admune inactivated influenza vaccine was administered intramuscularly to 31 healthy subjects (18 non-smokers and 13 cigarette smokers) and 30 patients with chronic bronchitis. Homologous haemagglutination inhibition (HI) antibody titres were measured in serum and respiratory secretions over a three-month post-vaccination period. Clinical reactions to the vaccine were recorded during the week following vaccination. Among healthy subjects cigarette smoking did not influence HI antibody responses in serum and nasal secretion following vaccination. Chronic bronchitics produced at least as much serum and nasal antibody as healthy subjects and their sputum and nasal secretion antibody responses were comparable. Clinical reactions to the vaccine were mild and well tolerated in all groups but seven patients with chronic bronchitis (23%) experienced increased respiratory symptoms during the week following vaccination.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7295522     DOI: 10.1016/0007-0971(81)90007-3

Source DB:  PubMed          Journal:  Br J Dis Chest        ISSN: 0007-0971


  4 in total

1.  Smoking, humoral immunity, and ulcerative colitis.

Authors:  E D Srivastava; J R Barton; S O'Mahony; D I Phillips; G T Williams; N Matthews; A Ferguson; J Rhodes
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

Review 2.  Does influenza immunisation cause exacerbations of chronic airflow obstruction or asthma?

Authors:  J M Watson; J F Cordier; K G Nicholson
Journal:  Thorax       Date:  1997-02       Impact factor: 9.139

Review 3.  Immune and inflammatory function in cigarette smokers.

Authors:  P G Holt
Journal:  Thorax       Date:  1987-04       Impact factor: 9.139

4.  The effect of smoking on influenza, influenza vaccination efficacy and on the antibody response to influenza vaccination.

Authors:  M Cruijff; C Thijs; T Govaert; K Aretz; G J Dinant; A Knottnerus
Journal:  Vaccine       Date:  1999-02-05       Impact factor: 3.641

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.